Unverified50% confidenceEventExact time

Neuralink在2023年获得IDE批准，2024年完成首例人体植入，目前处于早期临床验证阶段

1

Sources

50%

Confidence

Medium-term (~90 days)

Relevance

8/21/2026

First Seen

Valid until: 11/19/2026

Sources

Behind Neuralink's Mass Production: A Complete Analysis of BCI Patent Wars and Technology Origins

Related Claims

Unverified2023-2024年是医疗AI从概念验证向规模化部署的关键转折期60% similar UnverifiedA2A协议在2026年4月正式推至1.0版本59% similar Unverified美国FDA已于2023年发布专项指南，认可合成医疗数据在特定条件下的监管有效性58% similar UnverifiedLlamaFactory was accepted at ACL 202458% similar Unverified2023年FDA发布了AI/ML药物开发讨论文件，但仅是初步探索57% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/781320

API

curl https://kongchang.com/api/v1/knowledge/claims/781320

MCP

get_claim(id=781320)